Plasma D ‐dimer concentrations predicting stroke risk and rivaroxaban benefit in patients with heart failure and sinus rhythm: an analysis from the COMMANDER‐HF trial

ConclusionIn COMMANDER ‐HF, rivaroxaban reduced the risk of stroke but the benefit may be confined to patients with D‐dimer concentrations above 515ng/mL. Prospective trials are warranted to confirm these findings.

Source: European Journal of Heart Failure - September 20, 2020 Category: Cardiology Authors: Jo ão Pedro Ferreira, Carolyn S. P. Lam, Stefan D. Anker, Mandeep R. Mehra, Dirk J. Veldhuisen, William M. Byra, David A. La Police, John G. F. Cleland, Barry Greenberg, Faiez Zannad Tags: Research Article Source Type: research